Acelot, a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need, today announced the initiation of the Phase Ia clinical trial of ACE-2223 ...
Trail Edition returned to Leadville for the second year, partnering with Colorado Mountain College Leadville’s cross-country ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results